CH587289A5 - - Google Patents

Info

Publication number
CH587289A5
CH587289A5 CH775573A CH775573A CH587289A5 CH 587289 A5 CH587289 A5 CH 587289A5 CH 775573 A CH775573 A CH 775573A CH 775573 A CH775573 A CH 775573A CH 587289 A5 CH587289 A5 CH 587289A5
Authority
CH
Switzerland
Application number
CH775573A
Original Assignee
Jenapharm Veb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DE2323812A priority Critical patent/DE2323812A1/de
Priority to AT423873A priority patent/AT323911B/de
Priority to GB2436073A priority patent/GB1378262A/en
Application filed by Jenapharm Veb filed Critical Jenapharm Veb
Priority to FR7319540A priority patent/FR2231673B1/fr
Priority to CH775573A priority patent/CH587289A5/xx
Priority to NL7307464A priority patent/NL7307464A/xx
Priority to US383445A priority patent/US3864365A/en
Publication of CH587289A5 publication Critical patent/CH587289A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0066Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074Esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051Estrane derivatives
    • C07J1/0066Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0077Ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0088Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing unsubstituted amino radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
CH775573A 1973-05-11 1973-05-29 CH587289A5 (xx)

Priority Applications (7)

Application Number Priority Date Filing Date Title
DE2323812A DE2323812A1 (de) 1973-05-11 1973-05-11 Verfahren zur herstellung von kohlensaeurederivaten der oestranreihe
AT423873A AT323911B (de) 1973-05-11 1973-05-15 Verfahren zur herstellung von kohlensäurederivaten der östranreihe
GB2436073A GB1378262A (en) 1973-05-11 1973-05-22 Carbonic acid derivatives of oestradiol
FR7319540A FR2231673B1 (xx) 1973-05-11 1973-05-29
CH775573A CH587289A5 (xx) 1973-05-11 1973-05-29
NL7307464A NL7307464A (xx) 1973-05-11 1973-05-29
US383445A US3864365A (en) 1973-05-11 1973-07-27 Carbonic acid derivatives of estradiol and processes for their production

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DE2323812A DE2323812A1 (de) 1973-05-11 1973-05-11 Verfahren zur herstellung von kohlensaeurederivaten der oestranreihe
AT423873A AT323911B (de) 1973-05-11 1973-05-15 Verfahren zur herstellung von kohlensäurederivaten der östranreihe
GB2436073A GB1378262A (en) 1973-05-11 1973-05-22 Carbonic acid derivatives of oestradiol
FR7319540A FR2231673B1 (xx) 1973-05-11 1973-05-29
CH775573A CH587289A5 (xx) 1973-05-11 1973-05-29
NL7307464A NL7307464A (xx) 1973-05-11 1973-05-29
US383445A US3864365A (en) 1973-05-11 1973-07-27 Carbonic acid derivatives of estradiol and processes for their production

Publications (1)

Publication Number Publication Date
CH587289A5 true CH587289A5 (xx) 1977-04-29

Family

ID=27560436

Family Applications (1)

Application Number Title Priority Date Filing Date
CH775573A CH587289A5 (xx) 1973-05-11 1973-05-29

Country Status (7)

Country Link
US (1) US3864365A (xx)
AT (1) AT323911B (xx)
CH (1) CH587289A5 (xx)
DE (1) DE2323812A1 (xx)
FR (1) FR2231673B1 (xx)
GB (1) GB1378262A (xx)
NL (1) NL7307464A (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2668945B1 (fr) * 1990-11-12 1993-02-19 Theramex Nouveau procede de cristallisation des substances organiques et les composes ainsi obtenus.
US6175017B1 (en) * 1991-10-22 2001-01-16 Bayer Aktiengesellschaft Process for the production of aryl carbonates
EP0904084A4 (en) * 1996-05-16 2001-02-07 Gynetics Inc EMERGENCY CONCEPT PREVENTION KIT
FR2767823B1 (fr) * 1997-08-27 1999-10-15 Oreal Composes derives d'aminophenol et leur utilisation en cosmetique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR843426A (fr) * 1937-09-27 1939-07-03 Ste Ind Chim Bale Procédé de préparation de nouveaux éthers-sels de la série de la dihydrooestrine, possédant des groupes hydroxyles phénoliques libres
FR2047887A1 (en) * 1968-12-23 1971-03-19 Jenapharm Veb 1-halogeno-2-aminocarbonyloxy steroid - derivs for use as intermediates

Also Published As

Publication number Publication date
DE2323812A1 (de) 1974-11-28
NL7307464A (xx) 1974-12-03
FR2231673B1 (xx) 1977-12-30
GB1378262A (en) 1974-12-27
FR2231673A1 (xx) 1974-12-27
US3864365A (en) 1975-02-04
AT323911B (de) 1975-08-11

Similar Documents

Publication Publication Date Title
AR201758A1 (xx)
AU476761B2 (xx)
AU465372B2 (xx)
AR201235Q (xx)
AU474593B2 (xx)
AU474511B2 (xx)
AU474838B2 (xx)
AU471343B2 (xx)
AU465453B2 (xx)
AU465434B2 (xx)
AU450229B2 (xx)
AU476714B2 (xx)
AR201229Q (xx)
AU466283B2 (xx)
AU476696B2 (xx)
AU472848B2 (xx)
FR2231673B1 (xx)
AU477823B2 (xx)
AU447540B2 (xx)
AU476873B1 (xx)
AR201432A1 (xx)
AU461342B2 (xx)
AU477824B2 (xx)
AR210729A1 (xx)
AR193950A1 (xx)

Legal Events

Date Code Title Description
PL Patent ceased